Format

Send to

Choose Destination
Diabetes. 2016 Nov;65(11):3289-3300. Epub 2016 Aug 5.

Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity.

Author information

1
Children's Hospital Research Institute of Manitoba, Department of Pharmacology & Therapeutics, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
2
Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO.
3
Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD.
4
Diagnostic Services of Manitoba, Winnipeg, Canada.
5
Children's Hospital Research Institute of Manitoba, Department of Pharmacology & Therapeutics, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada ghatch@chrim.ca.

Abstract

Mitochondria are the nexus of energy metabolism, and consequently their dysfunction has been implicated in the development of metabolic complications and progression to insulin resistance and type 2 diabetes. The unique tetra-acyl phospholipid cardiolipin (CL) is located in the inner mitochondrial membrane, where it maintains mitochondrial integrity. Here we show that knockdown of Tafazzin (TAZ kd), a CL transacylase, in mice results in protection against the development of obesity, insulin resistance, and hepatic steatosis. We determined that hypermetabolism protected TAZ kd mice from weight gain. Unexpectedly, the large reduction of CL in the heart and skeletal muscle of TAZ kd mice was not mirrored in the liver. As a result, TAZ kd mice exhibited normal hepatic mitochondrial supercomplex formation and elevated hepatic fatty acid oxidation. Collectively, these studies identify a key role for hepatic CL remodeling in regulating susceptibility to insulin resistance and as a novel therapeutic target for diet-induced obesity.

PMID:
27495222
PMCID:
PMC5079636
DOI:
10.2337/db16-0114
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center